Top-News

Essa Pharma Aktie News

Aktie
WKN:  A2JKQ4 ISIN:  CA29668H7085 US-Symbol:  EPIX Branche:  Biotechnologie Land:  Kanada
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Marktkapitalisierung *
7,66 Mio. €
Streubesitz
20,68%
KGV
-
Dividende
1,69 $
Index-Zuordnung
-

Essa Pharma News

09.10.25 - PR Newswire
ESSA Announces Completion of Arrangement with XenoTherapeutics
ESSA Announces Completion of Arrangement with XenoTherapeutics PR Newswire
06.10.25 - PR Newswire
ESSA Securityholders Approve Acquisition by XenoTherapeutics
ESSA Securityholders Approve Acquisition by XenoTherapeutics PR Newswire
30.09.25 - PR Newswire
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order PR Newswire
24.09.25 - PR Newswire
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics PR Newswire
10.09.25 - PR Newswire
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025 PR Newswire
25.08.25 - PR Newswire
Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution PR Newswire
14.08.25 - PR Newswire
Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Essa Pharma Inc. Announces Ex-​Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution PR Newswire
06.08.25 - PR Newswire
Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders
Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders PR Newswire
01.08.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BGSF, COOP, EPIX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BGSF, COOP, EPIX on Behalf of Shareholders PR Newswire
23.07.25 - PR Newswire
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders PR Newswire
14.07.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DALN, RGLD, EPIX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DALN, RGLD, EPIX on Behalf of Shareholders PR Newswire
14.07.25 - PR Newswire
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction PR Newswire
08.05.25 - PR Newswire
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 PR Newswire
25.03.25 - PR Newswire
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX ...
24.03.25 - PR Newswire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX PR Newswire
21.03.25 - PR Newswire
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX PR Newswire
21.03.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX PR Newswire
20.03.25 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX PR Newswire
19.03.25 - PR Newswire
EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm
EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
18.03.25 - PR Newswire
EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »